Prescribing Patterns of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with CKD: A Cross-Sectional Registry Analysis.
Min ZhuoJiahua LiLeo F BuckleySri Lekha TummalapalliDavid B MountDavid J R SteeleDavid J LucierMallika L MenduPublished in: Kidney360 (2022)
In this registry study, prescription of SGLT-2i was low in the CKD population, particularly among patients without diabetes.